858 Therapeutics Announces $50 Million Series B Financing
Sep 26, 2024 · 858 Therapeutics today announced it raised $50 million in a Series B financing led by Avidity Partners with participation from Insight Partners, Mirae
OFF
858 Therapeutics Announces $50 Million Series B Financing
6 days from now
Sep 26, 2024 · 858 Therapeutics today announced it raised $50 million in a Series B financing led by Avidity Partners with participation from Insight Partners, Mirae
businesswire.com
OFF
858 Therapeutics Announces $50 Million Series B Financing
6 days from now
Sep 27, 2024 · SAN DIEGO--(BUSINESS WIRE)--858 Therapeutics today announced it raised $50 million in a Series B financing led by Avidity Partners with participation from Insight …
biospace.com
OFF
858 Therapeutics Announces $50 Million Series B Financing
6 days from now
SAN DIEGO, September 26, 2024--858 Therapeutics today announced it raised $50 million in a Series B financing led by Avidity Partners with participation from Insight Partners, Mirae Asset …
yahoo.com
OFF
858 Therapeutics Secures $50 Million To Propel Cancer Drug …
6 days from now
Sep 30, 2024 · Recently, 858 Therapeutics, a San Diego-based company, secured a significant boost of $50 million in Series B financing. This funding round was led by Avidity Partners, with …
parsers.vc
OFF
858 Therapeutics Secures $50M Series B Financing To Advance …
6 days from now
Oct 3, 2024 · 858 Therapeutics raised $50M in Series B led by Avidity Partners, advancing its lead PARG inhibitor ETX-19477 for cancer treatment. ... 858 Therapeutics Secures $50M …
sliceofhealthcare.com
OFF
858 Therapeutics Raises $50 Million In Series B Funding To …
6 days from now
Sep 26, 2024 · 858 Therapeutics has secured $50 million in a Series B funding round led by Avidity Partners, with participation from Insight Partners, Mirae Asset Capital, and Alexandria …
siliconvalleyjournals.com
OFF
858 Therapeutics Secures $50M Series B Funding
6 days from now
Sep 30, 2024 · SAN DIEGO—858 Therapeutics has successfully secured $50 million in a Series B funding round. The financing was spearheaded by Avidity Partners and saw contributions …
patsnap.com
OFF
858 Therapeutics: Drug Discovery Company Raises $50 Million …
6 days from now
Sep 28, 2024 · 858 Therapeutics announced it raised $50 million in a Series B financing led by Avidity Partners. Participation came from Insight Partners, Mirae Asset Capital, and Alexandria …
pulse2.com
OFF
858 Therapeutics Raises $50M In Series B Financing Round
6 days from now
Sep 27, 2024 · Funds will be used to advance a Phase I trial of 858's PARG inhibitor ETX-19477 in advanced solid tumors. ... 858 Therapeutics on Thursday said it raised $50 million in a …
precisionmedicineonline.com
OFF
858 Therapeutics Raises $50M In Series B Financing - Finsmes.com
6 days from now
Sep 27, 2024 · 858 Therapeutics, a San Diego, CA-based biotechnology and drug discovery company, raised $50M in Series B funding.. The round was led by Avidity Partners with …
finsmes.com
OFF
858 Therapeutics Secures $50 Million In Series B Funding To …
6 days from now
858 Therapeutics, an innovative biotechnology and drug discovery company specializing in oncology, has successfully raised $50 million in its latest funding round. This significant capital …
leadsontrees.com
OFF
858 Therapeutics Announces $50 Million Series B Financing
6 days from now
Sep 26, 2024 · SAN DIEGO — 858 Therapeutics today announced it raised $50 million in a Series B financing led by Avidity Partners with participation from Insight Partners, Mirae Asset …
financialpost.com
OFF
858 Therapeutics Raises $50 Million In Series B Funding To Advance ...
6 days from now
Sep 26, 2024 · 858 Therapeutics has raised $50 million in a Series B financing round led by Avidity Partners, involving other investors. This funding will be used to progress the …
bio-research.ai
OFF
858 Therapeutics Secures $50M In Series B Round For Innovations
6 days from now
Sep 26, 2024 · In a significant stride towards advancing its ongoing projects, 858 Therapeutics has successfully secured $50 million in a Series B financing round. This financing, led by …
investorshangout.com
OFF
Series B - 858 Therapeutics - 2024-09-26 - Crunchbase Funding …
6 days from now
Funding Type Series B; Funding Stage Early Stage Venture; Money Raised . $50M. ... News — 858 Therapeutics Announces $50 Million Series B Financing . ... News • Sep 26, 2024. …
crunchbase.com
OFF
858 Therapeutics | The Pharmaletter
6 days from now
Latest 858 Therapeutics News. 858 Therapeutics secures $50 million in series B funding. 27 September 2024. ... Agomab secures $89 million Series D financing . 25 October 2024. …
thepharmaletter.com
OFF
858 Therapeutics Announces $50 Million Series B Financing
6 days from now
Sep 26, 2024 · 858 Therapeutics today announced it raised $50 million in a Series B financing led by Avidity Partners with participation from Insight Partners, Mirae Asset Capital, and …
wedbush.com
FAQs about 858 Therapeutics Announces $50 Million Series B Financing Coupon?
Who financed 858 Therapeutics?
Why did 858 get a series B financing?
Who is joining 858 Therapeutics' Board of directors?
Did avidity raise $50 million in a series B financing?
What will 858 Therapeutics do with etx-19477?
Install CouponFollow Extension on Chrome
Install the CouponFollow extension to search for discount codes when shopping the fastest!
Install CouponFollow Chrome Extension
Listing Store by Characters
